Literature DB >> 30251284

Commentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment.

Christine Timko1,2, Michael A Cucciare3,4,5.   

Abstract

Entities:  

Keywords:  Cannabis; contingency management; opioid agonist treatment; opioids; outcomes; retention

Mesh：

Substances：

Year:  2018        PMID： 30251284      PMCID： PMC6542466          DOI： 10.1111/add.14432

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  19 in total

Review 1.  Retention in medication-assisted treatment for opiate dependence: A systematic review.

Authors:  Christine Timko; Nicole R Schultz; Michael A Cucciare; Lisa Vittorio; Christina Garrison-Diehn
Journal:  J Addict Dis       Date:  2015-10-14

2.  The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada.

Authors:  Alexandra M Franklyn; Joseph K Eibl; Graham J Gauthier; David Pellegrini; Nancy E Lightfoot; David C Marsh
Journal:  Int J Drug Policy       Date:  2017-06-27

3.  Enhancing transitions from addiction treatment to primary care.

Authors:  Michael A Cucciare; Eric A Coleman; Richard Saitz; Christine Timko
Journal:  J Addict Dis       Date:  2014

Review 4.  The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.

Authors:  Kathleen M Carroll; Roger D Weiss
Journal:  Am J Psychiatry       Date:  2016-12-16       Impact factor: 18.112

Review 5.  Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.

Authors:  Kevin P Hill
Journal:  JAMA       Date:  2015 Jun 23-30       Impact factor: 56.272

Review 6.  Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against.

Authors:  D H Epstein; K L Preston
Journal:  Addiction       Date:  2003-03       Impact factor: 6.526

7.  Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.

Authors:  Yih-Ing Hser; Andrew J Saxon; David Huang; Al Hasson; Christie Thomas; Maureen Hillhouse; Petra Jacobs; Cheryl Teruya; Paul McLaughlin; Katharina Wiest; Allan Cohen; Walter Ling
Journal:  Addiction       Date:  2013-10-09       Impact factor: 6.526

Review 8.  Adverse health effects of marijuana use.

Authors:  Nora D Volkow; Ruben D Baler; Wilson M Compton; Susan R B Weiss
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

9.  Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective Study.

Authors:  Aurélie Mayet; Caroline Lions; Perrine Roux; Marion Mora; Gwenaelle Maradan; Alain Morel; Laurent Michel; Catherine Marimoutou; Maria Patrizia Carrieri
Journal:  J Subst Abuse Treat       Date:  2015-07-03

10.  The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada.

Authors:  Alexandra M Franklyn; Joseph K Eibl; Graham J Gauthier; David C Marsh
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.